drugset / Trial / NCT01497587

Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

NCT01497587

Phase 1 Completed 20 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Asia. The aim of this trial is to investigate pharmacokinetics of insulin detemir in healthy Taiwanese subjects.

Timeline

Start
2005-08
Primary completion
2005-12
Completion
2005-12

Publications

  • Results Kwok C-F, Tsai T-H, Lim S-H, Vaz J, Ho L-T. The Pharmacokinetic Profile of Insulin Detemir in Healthy Male Taiwanese and Caucasian Subjects. ASEAN Federation of Endocrine Societies (AFES); Country: Malaysia City: Kuala Lumpur

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic 0.5 iu/kg Subcutaneous

Indications